Dipeptidylpeptidase Inhibition Is Associated with Improvement in Blood Pressure and Diastolic Function in Insulin-Resistant Male Zucker Obese Rats

Diastolic dysfunction is a prognosticator for future cardiovascular events that demonstrates a strong correlation with obesity. Pharmacological inhibition of dipeptidylpeptidase-4 (DPP-4) to increase the bioavailability of glucagon-like peptide-1 is an emerging therapy for control of glycemia in typ...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Aroor, Annayya R., Sowers, James R., Bender, Shawn B., Nistala, Ravi, Garro, Mona, Mugerfeld, Irina, Hayden, Melvin R., Johnson, Megan S., Salam, Muhammad, Whaley-Connell, Adam, DeMarco, Vincent G.
Formato: Artigo
Idioma:Inglês
Publicado em: Endocrine Society 2013
Assuntos:
Renal-Cardiac-Vascular
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3689282/
https://ncbi.nlm.nih.gov/pubmed/23653460
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/en.2013-1096
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados